$EDXC Expands Cannsumable(C) Portfolio With Launch of CBD Unlimited

Endexx Corporation (EDXC), a provider of innovative medical marijuana management and technology solutions, is pleased to announce the expansion of its Cannsumable© asset portfolio with the addition and launch of a new proprietary e-commerce site, CBDUnlimited.com (https://www.cbdunlimited.com/).

Since early 2014, Endexx has secured a high quality supply chain of imported industrial hemp based Cannabidiol (CBD) extracts and nutritional products. Endexx has been testing formulations and delivery systems through volunteers, patients and customers representing a wide demographic range for important criteria like usability, effectiveness, taste and overall experience. Significant feedback was gathered and used to help develop Phyto-Nutrient© rich solutions for health.

Endexx management and its expert advisors are secure in the knowledge that its products meet the highest standards of quality and have demonstrated they deliver distinct benefits to its targeted audience of health-conscious individuals of all ages.

The Company’s initial product brands are M3CBD© and M3Vape©. Our mission is to provide Phyto-Nutrients© and Phyto-Delivery© systems that optimize the efficacy of CBD enriched products derived from “Eco-Farmed” and organically grown “Industrial Hemp.” The M3CBD© line of products carries a full, naturally occurring cannabinoid and terpene profile that stimulates the release of our natural endocannabinoids and enhances the body’s innate endocannabinoid response. All products offered carry a Certificate of Analysis (COA) ensuring the products are toxin and contaminant free and contain less the .03 percent THC providing a legal alternative to Medical Marijuana. Multiple products will be introduced to our customers in the coming months.

CBD Health Solutions LLC, a provider and distributor of nutraceutical and health related products acquired by Endexx earlier this year, participated at the Denver Cannabis Cup on April 18-20. Their unique line of products generated strong interest and overwhelmingly positive feedback, with all products selling out on the first day of the show.

Here are written testimonials about CBD Health Solutions’ special cannabinoid and terpene rich formulation from visitors at the Cannabis Cup:

Daniel S. wrote, “The soothing and relaxing effect was noticeable without a doubt on the very first try. I am thankful to try this product so I can live with MS (Multiple Sclerosis) without any trouble. Thank you very much sir. My friend, who was diagnosed with brain cancer, said that one dropper full was enough, that she woke up, NOT nauseous and WITHOUT a headache for the first time in 50 days.”

Endexx is rapidly expanding its salesforce for both CBD Health Solutions LLC., and CBD Unlimited nationwide, reaching new retail markets every day as Cannabidiol becomes increasingly recognized and accepted as a natural compound for health. After several months of market exploration, feedback from vendors has exceeded early forecasts. Products are selling out rapidly and retailers continue to increase the size of their orders, as loyal customers return for more and share their experience to friends and family. Individual customer testimonies can be found on both websites.

We expect retail sales to grow by 20 to 30 percent per quarter through 2017. Sales are projected to exceed $1 million in the next 12 months. That is the equivalent of 800,000 daily doses on year one, enough to supply 2,000 regular patients and users for one year.

Dylan Trotter of CBD Health Solutions stated, “A majority of sales came as a result of attendees who sampled our “Canna Joos,” then came back after trying other CBD products at the show, ultimately informing us they chose to purchase our Canna Joos due to its unique taste and the quality of the experience.”

Todd Davis, CEO Endexx, added, “After observing 13 patients and dozens of individual people try and test the products over the past year, we have witnessed an alternative health product benefiting all who have used it. Repeat sales and use are immediate and we expect strong sales growth from the entire Cannsumable division. Since acquiring CBD Health Solutions, we have rapidly expanded our Cannsumable© asset portfolio, increased our sales and sales force and launched a new e-commerce site which makes it easier to order products, adds value for our customers, and opens up a new sales channel. We are thrilled about our progress and are actively working to increase our retail markets.”

We invite you to visit our sites and partake of our offerings:

www.cbdunlimited.com

and

www.cbdhealthsolutions.com

About Endexx

Endexx provides innovative medical marijuana management and technology solutions. Endexx with its collaboration partners and consultants develops and distributes two consumable product lines derived from industrial hemp that is organic and naturally rich in phytocannabinoids. The company has two technology products and services that launched in 2014 — the M3hub and the Autospense. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana to maintain compliance with the laws of National and State governments, and local regulatory bodies, as well as, provide a smooth transition to the eventual Federal mandates. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites are www.cbdunlimited.com , www.cbdhealthsolutions.com , www.endexx.com ,www.m3hub.com .

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

For further investor and media information, contact:

Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
480-595-6900

or

Irth Communications, LLC.
310-220-4294